The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk
Article in Pharmacological Research (March 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Pharmacological Research (March 2024)
Article in Frontiers in Pharmacology (June 2023)